Inhibitors of lysine methyl transferase
US9822103B2 · kind B2 · utility
7Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2014 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | Nov 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are disclosed compounds that are inhibitors of EZH2, pharmaceutical compositions containing said compounds and methods of treating hyperproliferative, inflammatory, infectious, and immunoregulatory disorders and diseases utilizing the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.